Changes in the BDNF/proBDNF ratio have been measured in the peripheral blood and cerebrospinal fluid of both animal models and human patients with Alzheimer’s, Parkinson’s, and Huntington’s disease. The gene discussed is BDNF; the disease is Huntington disease.